08
January
2025


Share on networks

Pharmaceutical company Bayer has recently launched a new R&D division for health and agriculture at its shared services centre in Sant Joan Despí, Barcelona, adding 82 new professionals. This unit will serve the multinational’s various divisions by developing operations for clinical trials and managing safety and quality processes for medicines.

Bayer’s shared services centre in Sant Joan Despí, established in 2001, plays a key role in the company’s transformation and digitalisation efforts and serves as a global benchmark in implementing new operational models. The centre’s team comprises professionals from over 50 nationalities and undertakes internationally oriented projects, providing services to more than eleven countries across Europe and the Middle East.

With the launch of this new R&D division, the centre further strengthens its position as a hub of excellence within Bayer’s organisation. Since its opening, the centre has progressively incorporated new areas of development, specialising in the application of artificial intelligence to improve efficiency, traceability and agility in its processes.

According to the company, this milestone would not have been possible without collaboration with public and private institutions in the country and a favourable ecosystem for job creation and economic development. Over the past five years, the centre’s workforce has grown by 75%, increasing from 471 to 822 professionals with scientific expertise.

 

Share on networks

Related news

Llum verda a l’ampliació de l’aeroport del Prat: una inversió de 3.200 milions d’euros per assolir els 70 milions de passatgers

News

El Prat airport expansion gets green light: €3.2 billion to be invested to reach 70 million passengers

Barcelona, entre el ‘top cinc’ dels principals hubs de startups de la Unió Europea per segon any consecutiu

News

Barcelona among top five start-up hubs in European Union for second year in a row

El nou Campus Barcelona de Smith+Nephew consolida Catalunya com a referent de la innovació sanitària a Europa

News

New Smith+Nephew Barcelona Campus consolidates Catalonia as European benchmark in healthcare innovation

Les ciències de la vida a Catalunya es consoliden com a eix d’innovació i creixement: 220 milions d’inversió i 8,7% del PIB

News

Consolidation of life sciences in Catalonia as driving force for innovation and growth: €220 million invested and 8.7% of GDP

Barcelona Catalonia
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.